Showing results (601-610 of 7,006) with videos related to
Sort By:
Pageof 701
Lung Cancer (Amsterdam, Netherlands)|July 14, 1999
Short-term chemotherapy and palliative radiotherapy for elderly patients with stage IV non-small cell lung cancer: a phase II studyB Jeremic, Y Shibamoto, B Milicic, et al.Lung Cancer (Amsterdam, Netherlands)|July 21, 1999
Gap junctional communication in cultured human lung carcinoma cellsE Tomai, H L Brownell, T V Tufescu, et al.Lung Cancer (Amsterdam, Netherlands)|July 21, 1999
Chemoradiation for inoperable non small cell lung cancer: a phase II study using a regimen with acceptable toxicityB H Burmeister, N K Gogna, G P Bryant, et al.Lung Cancer (Amsterdam, Netherlands)|September 21, 2000
The prognostic value of DNA content analysis in patients with squamous cell lung cancer treated surgicallyW Dyszkiewicz, M Kasprzyk, C Piwkowski, et al.Lung Cancer (Amsterdam, Netherlands)|September 21, 2000
Diagnostic and therapeutic management of neuroendocrine lung tumors: a clinical study of 44 casesA Carretta, G L Ceresoli, G Arrigoni, et al.Lung Cancer (Amsterdam, Netherlands)|August 30, 2000
Second-line chemotherapy for recurrent non-small cell lung cancer: do new agents make a difference?D Ferrigno, G BuccheriLung Cancer (Amsterdam, Netherlands)|September 29, 2000
A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysisC Mascaux, M Paesmans, T Berghmans, et al.Lung Cancer (Amsterdam, Netherlands)|February 18, 1999
Weekly systemic combination of cisplatin and interferon alpha 2a in diffuse malignant pleural mesotheliomaA Purohit, L Moreau, A Dietemann, et al.Lung Cancer (Amsterdam, Netherlands)|February 18, 1999
Induction chemoradiotherapy for advanced stage III non-small cell lung cancer: long-term follow-up in 42 patientsN Katakami, M Okazaki, S Nishiuchi, et al.Lung Cancer (Amsterdam, Netherlands)|February 18, 1999
Cancer-associated retinopathy in a patient with non-small-cell lung carcinomaR Salgia, T R Hedges, M Rizk, et al.Pageof 701